CIPROPTIC

This brand name is authorized in Nigeria.

Active ingredients

The drug CIPROPTIC contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6929	Ear/eye drops	CIPROPTIC EYE/EAR DROPS SOL_DROPS 0.3% 1 X 10ml	95 RNW-PP-264207 CIPROPTIC EYE/EAR DROPS CIPROFLOXACIN 0.3%W/V EACH 10ML BOTTLE CONTAINS CIPROFLOXACIN HYDROCHLORIDE BP EQ. TO CIPROFLOXACIN 0.3%W/V. HYDROXYPROPYL METHYL CELLULOSE BP 0.25%W/V, BENZALKONIUM CHLORIDE SOLUTIONS BP 0.02%W/V. AQUEOUS BUFFER SOLUTION Q.S B4-6929 Drugs Imported Products 1X10ML Prescription Only Medicine (POM) 5/12/2022 FANYVAL VISIONS LIMITED, NO 21 ROTIMI STREET, SURULERE LAGOS STATE 8063803298 fanyval2019@gmail.com M/S SCOTT-EDIL PHARMA CIA LIMITED, 56, E.P.I.P PHASE -1, JHARMAJRI, BADDI (H.P) DIST. SOLAN, INDIA., India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S03AA07	Ciprofloxacin	S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives
Discover more medicines within S03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6929